复方贞术调脂胶囊对糖皮质激素诱导骨质疏松大鼠股骨和腰椎骨密度及生物力学特性的研究

被引:12
作者
孙平 [1 ]
胡伶平 [2 ]
董群伟 [2 ]
蔡妹群 [2 ]
王晓东 [1 ]
郭姣 [3 ]
刘忠厚 [4 ]
机构
[1] 广东药学院附属第一医院骨质疏松基地
[2] 广东药学院附属第一医院骨科
[3] 国家中医药管理局高脂血症调肝降脂重点研究室广东药学院国家中医药管理局脂代谢三级实验室
[4] 中国老年学学会骨质疏松委员会
关键词
糖皮质激素; 复方贞术调脂胶囊; 骨密度; 骨生物力学; 骨质疏松;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的观察复方贞术调脂胶囊(FTZ)对糖皮质激素诱导骨质疏松大鼠股骨和腰椎骨密度及生物力学特性的影响。方法SPF级雄性SD大鼠32只,随机等分为4组:Nrm组为正常对照组,Met组为皮下注射甲强龙(Met)5 mg/(kg·d),每周5次,FTZL组和FTZH组在Met组基础上每日分别给予低剂量FTZ(1.5g/kg)和高剂量FTZ(6g/kg)灌胃,实验期为12w。QDR4500A型双能X线骨密度测定仪测定股骨和腰椎骨密度,MTS-858型生物力学实验机测定股骨和腰椎生物力学性能。结果Met组大鼠股骨和腰椎的骨密度、最大载荷、刚度、弹性模量、皮质骨厚度、股骨中段截面面积和椎体横断面面积均显著低于Nrm组相应指标(P<0.001,P<0.01),股骨骨髓腔面积显著高于Nrm组(P<0.01);FTZL组大鼠的股骨骨密度,最大载荷、刚度、弹性模量、皮质骨厚度、股骨中段截面面积和椎体横断面面积较Met组有升高趋势,股骨骨髓腔面积较Met组减少,但两组间各指标均无显著性差异(P>0.05);FTZH组大鼠股骨和腰椎的骨密度、最大载荷、刚度、弹性模量、皮质骨厚度和椎体横断面面积显著高于Met组相应指标(P<0.01,P<0.05),股骨骨髓腔面积显著低于Met组(P<0.05),股骨中段截面面积较Met组有增加趋势,但无显著性差异(P>0.05),FTZH组腰椎的骨密度和最大荷载显著高于FTZL组(P<0.05),余各项指标间无显著性差异(P>0.05)。结论高剂量FTZ对改善糖皮质激素诱导骨质疏松大鼠股骨和腰椎的骨密度及生物力学特性效果显著。
引用
收藏
页码:135 / 138+144 +144
页数:5
相关论文
共 12 条
[1]
Lipid metabolism disorders and bone dysfunction-interrelated and mutually regulated (Review) [J].
Tian, Li ;
Yu, Xijie .
MOLECULAR MEDICINE REPORTS, 2015, 12 (01) :783-794
[2]
Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women [J].
Li, Shuang ;
Guo, Hongbing ;
Liu, Youshuo ;
Wu, Feng ;
Zhang, Hongbing ;
Zhang, Zhimin ;
Xie, Zhongjian ;
Sheng, Zhifeng ;
Liao, Eryuan .
CLINICAL ENDOCRINOLOGY, 2015, 82 (01) :53-58
[3]
Potential synergistic effects of Chinese herbal prescription FTZ components detected in blood towards hepatic lipid-modulating targets [J].
Wang, Laiyou ;
Tao, Weiye ;
Luo, Duosheng ;
Hu, Yinming ;
Bei, Weijian ;
Guo, Jiao .
COMPLEMENTARY THERAPIES IN MEDICINE, 2014, 22 (05) :887-893
[4]
Statins as Bioactive Molecules to Support Bone Regeneration [J].
Brittain, Sarah B. ;
Gohil, Shalini V. ;
Nair, Lakshmi S. .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (25) :2980-2988
[5]
Relationship of lipid parameters with bone mineral density in Indian population.[J].M Garg;Raman Marwaha;Nikhil Tandon;Kuntal Bhadra;N Mahalle.Indian Journal of Endocrinology and Metabolism.2014, 3
[6]
Bone mineral density in statin users: a population-based analysis from a Spanish cohort [J].
Hernandez, Jose L. ;
Olmos, Jose M. ;
Romana, Galo ;
Martinez, Josefina ;
Castillo, Jesus ;
Yezerska, Irina ;
Pinedo, Gabriel ;
Gonzalez-Macias, Jesus .
JOURNAL OF BONE AND MINERAL METABOLISM, 2014, 32 (02) :184-191
[7]
Glucocorticoid-induced osteoporosis: pathophysiology and therapy [J].
Canalis, E. ;
Mazziotti, G. ;
Giustina, A. ;
Bilezikian, J. P. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) :1319-1328
[8]
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study [J].
Angeli, Alberto ;
Guglielmi, Giuseppe ;
Dovio, Andrea ;
Capelli, Giovanni ;
de Feo, Daniela ;
Giannini, Sandro ;
Giorgino, Ruben ;
Moro, Luigi ;
Giustina, Andrea .
BONE, 2006, 39 (02) :253-259
[9]
Prevention and treatment of nonpostmenopausal osteoporosis [J].
Hansen, LB ;
Vondracek, SF .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (24) :2637-2654
[10]
Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate [J].
Hulley, PA ;
Conradie, MM ;
Langeveldt, CR ;
Hough, FS .
BONE, 2002, 31 (01) :220-229